106 results
Page 3 of 6
8-K
EX-10.1
x12mgpg69
28 Jun 22
Diffusion Pharmaceuticals Announces Positive Effects in Altitude Trial
4:13pm
8-K
EX-99.1
y69p953y2h3eoizxy
23 May 22
Diffusion Pharmaceuticals Announces Appointment of Raven Jaeger, M.S., as Chief Regulatory Officer
5:42pm
8-K
EX-99.1
pzvueucaiol2
16 May 22
Diffusion Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-99.1
xf0yr0yg42a
4 May 22
Other Events
4:33pm
8-K
EX-99.1
s3xngb
18 Apr 22
Diffusion Pharmaceuticals Announces 1-for-50 Reverse Stock Split as Part of Nasdaq Compliance Plan
4:25pm
8-K
EX-99.1
k2a 2aiq4g
12 Apr 22
Diffusion Pharmaceuticals Completes Dosing in Altitude Trial
9:08am
DEFA14A
EX-99.1
bfd3gi53vn7tygcwi
8 Apr 22
Additional proxy soliciting materials
5:05pm
8-K
EX-99.1
1hbcqz 5apwmz3
8 Apr 22
Diffusion Pharmaceuticals Announces New Date for Previously Announced Special Meeting of Stockholders
5:04pm
8-K
EX-99.1
ecr8g a6h
21 Mar 22
Diffusion Pharmaceuticals Reports 2021 Financial Results and Provides Business Update
4:26pm
8-K
EX-99.1
8xsvcei ns6i7
21 Dec 21
Other Events
4:06pm
8-K
EX-99.1
shbplsa8 ltu7p
24 Nov 21
Other Events
4:15pm
8-K
EX-99.1
m9cvfzk
10 Nov 21
Diffusion Pharmaceuticals Reports Third Quarter Financial Results
8:01am
8-K
EX-99.1
yvd0qxm 3t
13 Sep 21
Diffusion Pharmaceuticals Issues Letter to Shareholders
4:09pm
8-K
EX-99.1
m6vwq
13 Aug 21
Diffusion Pharmaceuticals Reports Q2 Financial Results
4:30pm
8-K
EX-99.1
qavjjoqizppiq
30 Jun 21
Diffusion Pharmaceuticals Reports Positive Trend in Oxygenation from TCOM Trial
4:33pm
DEFA14A
af4908 cuw
21 Jun 21
Additional proxy soliciting materials
9:25am